Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.
SUNY Upstate Medical University, Syracuse, New York, United States
University of Southern California Adult Comprehensive Epilepsy Center, Los Angeles, California, United States
Neurosciences Institute at Albany Medical Center, Albany, New York, United States
Texas Children's Hospital, Houston, Texas, United States
Children's Hospital and Regional Medical Center, Seattle, Washington, United States
Miami Children's Hospital, The Brain Institute, Miami, Florida, United States
Le Bonheur Children's Medical Center, Memphis, Tennessee, United States
Miami Children's Hospital, The Brain Institute, Miami, Florida, United States
Texas Children's Hospital, Houston, Texas, United States